Heart failure Trials in Durham, United States
Conditions / Heart failure / Durham, United States
Clinical trials for Heart failure investigate a range of treatment strategies and patient populations.
123 total trials for this combination
Showing top 10 of 123 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01431326 | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | COMPLETED | — |
| NCT00271180 | Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products | RECRUITING | — |
| NCT02929329 | Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction | COMPLETED | PHASE3 |
| NCT06677060 | Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin | RECRUITING | PHASE3 |
| NCT00358215 | RED-HFâ„¢ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial | COMPLETED | PHASE3 |
| NCT02111564 | A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients | COMPLETED | PHASE3 |
| NCT00979225 | Clinical Decision Support for Medication Management and Adherence | COMPLETED | NA |
| NCT05636176 | A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation | RECRUITING | PHASE3 |
| NCT04278404 | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | RECRUITING | — |
| NCT03057977 | EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) | COMPLETED | PHASE3 |